Is cardiac surgery warranted in children with Down syndrome? A case-controlled review

M A Roussot1, J B Lawrenson, J Hewitson

  • 1Division of Critical Care and Children's Heart Diseases, School of Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children's Hospital, Rondebosch, Cape Town, South Africa.

Insights

Children with Down syndrome (DS) and those without experienced similar healthcare burdens after congenital heart disease surgery. Denying DS children surgery is not a viable resource allocation strategy.

Area of Science:

  • Pediatric Cardiology
  • Health Services Research
  • Genetics

Background:

  • Congenital heart disease (CHD) is a common comorbidity in children with Down syndrome (DS).
  • Resource allocation in healthcare is a critical consideration, particularly for specialized surgical interventions.

Purpose of the Study:

  • To compare the healthcare system burden of children with and without Down syndrome undergoing congenital heart disease repair.
  • To investigate the impact of Down syndrome on outcomes following cardiac surgery.

Main Methods:

  • Retrospective case-control study at Red Cross War Memorial Children's Hospital, Cape Town.
  • Compared 50 children with Down syndrome to 50 non-syndromic children who underwent cardiac surgery (1998-2003).
  • Outcome measures included hospital/ICU stay, complication rates, re-operation, and mortality.

Main Results:

  • No significant difference in healthcare system burden between the Down syndrome and control groups.
  • Similar complication, re-operation, and early mortality rates were observed in both groups.
  • Children with Down syndrome appeared to derive greater benefit from cardiac surgery.

Conclusions:

  • Denying cardiac surgery to children with Down syndrome does not improve healthcare resource allocation efficiency.
  • Discrimination against children with Down syndrome is not a justifiable approach to managing scarce resources.
  • Equitable access to cardiac surgery for children with Down syndrome is supported by these findings.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...